Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Biologists have discovered a new type of RNA-splicing regulation that helps to determine which protein-coding exons will be included in messenger RNA transcripts. RNA splicing is a cellular ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, portions of the RNA that don't code for proteins, called introns ...

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

Kwok and colleagues’ work focuses on a newly recognized form of cancer mutation that arises from abnormal mRNA splicing. Splicing is a processing event in which non-coding segments called ...

RNA splicing is a cellular process that is critical for gene expression. After genes are copied from DNA into messenger RNA, portions of the RNA that don't code for proteins, called introns ...

LncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...